Skip to main content
Log in

Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma

  • Oncology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

While cigarette smoking and alcohol consumption have been linked to laryngeal squamous cell carcinoma (SCC), the role of genetic factors in determining individual susceptibility is unknown. We describe the role of allelism at the glutathione S-transferase GSTM1, GSTM3, GSTT1 and cytochrome P450 CYPIA1, CYP2E1, CYP2D6 loci in determining individual susceptibility to laryngeal SCC. Enzyme genotypes were determined using polymerase chain reaction and restriction enzyme digestion of leukocyte DNA collected from 269 patients with T1–T4 laryngeal carcinomas and 216 controls. While the frequencies of the heterozygote GSTM1 A/B genotype and the homozygote GSTM3 B/B genotype were statistically significantly lower in the patients with tumors than in controls, the frequency of the GSTT1 null genotype was higher in the patients than in controls. The data suggest that allelism at GST loci mediates susceptibility to SCC of the larynx. GSTM1 A/B and GSTM3 B/B appear to be associated with reduced risk, while GSTT1 null may confer increased risk. These findings are compatible with the view that genetic predisposition is important in determining risk for this cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Heagerty AHM, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L, Alldersea J, Strange RC (1994) Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 343: 266–268

    Article  PubMed  CAS  Google Scholar 

  2. Inskip A, Elexperu-Camiruaga J, Buxton N, Dias PS, MacIntosh J, Campbell D, Jones PW, Yengi L, Talbot A, Strange RC, Fryer AA (1995) Identification of polymorphism at the glutathione Stransferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 312: 713–716

    PubMed  CAS  Google Scholar 

  3. Irish JC (1994) Oncogenes in head and neck cancer: erb-B and ras oncogene activation in laryngeal carcinoma. In: Smee R, Bridger GP (eds) Laryngeal cancer. Proceedings, 2nd World Congress on Laryngeal Cancer, Sydney, 20–24 February 1994. Elsevier, Amsterdam, p 172

    Google Scholar 

  4. Jahnke V (1995) Bösartige Tumoren des Larynx. In: Naumann HH, Helms J, Herberhold C, Kastenbauer E (eds) Oto-RhinoLaryngologie in Klinik und Praxis, vol 3, Hals. Thieme, Stuttgart, p 388

    Google Scholar 

  5. Maier H, Gewelke U, Dietz A, Heller WD (1991) Kehlkopfkrebsrisiko bei chronischem Tabak- und/oder Alkoholkonsum. Otorhinolaryngol Nova 1: 271–277

    Google Scholar 

  6. Pemble S, Schröder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of the genetic polymorphism. Biochem J 300: 271–276

    PubMed  CAS  Google Scholar 

  7. Strange RC (1993) The glutathione S-transferase GSTM1 locus and cancer susceptibility. In: Tew K, Mannervik B, Mantle TJ, Pickett CB, Hayes JD (eds) Structure and function of glutathione transferases. CRC Press, Boca Raton, p 160

    Google Scholar 

  8. Wolf CR, Smith CAD, Gough AC (1992) Relationship between the debrisoquine polymorphism and cancer susceptibility. Carcinogenesis 13: 1035–1038

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Prize paper: European award by “Unione Mutilati della Voce” as best paper in the field on malignant tumors of the larynx

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jahnke, V., Strange, R., Matthias, C. et al. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma. Eur Arch Otorhinolaryngol 254 (Suppl 1), S147–S149 (1997). https://doi.org/10.1007/BF02439747

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02439747

Key words

Navigation